Concepedia

Publication | Closed Access

Bax inhibitor‐1 protects from nonalcoholic steatohepatitis by limiting inositol‐requiring enzyme 1 alpha signaling in mice

DOI

110

Citations

32

References

2018

Year

Cynthia Lebeaupin, Déborah Vallée, Déborah Rousseau, Stéphanie Patouraux, Stéphanie Bonnafous, Gilbert Adam, Frédéric Luciano, Carmelo Luci, Rodolphe Anty, Antonio Iannelli,
Hepatology

Abstract

Targeting IRE1α-dependent NLRP3 inflammasome signaling with pharmacological agents or by BI-1 may represent a tangible therapeutic strategy for NASH. (Hepatology 2018).

References

YearCitations

Page 1